FDA approves nasal spray as first self-administered flu vaccine

The FDA on Friday approved the first ever influenza vaccine that does not have to be given by a health care professional.
FluMist, an existing nasal spray vaccine, is now approved for self- or caregiver-administration in people aged 2 to 49 years, the FDA announced.
The live-attenuated vaccine contains weakened influenza viruses, as opposed to influenza vaccines given as injections, which contain inactivated viruses.
AstraZeneca announced last year that the FDA had accepted its supplemental biologics license application for FluMist to be approved as a self-administered vaccine. The application

The FDA on Friday approved the first ever influenza vaccine that does not have to be given by a health care professional.
FluMist, an existing nasal spray vaccine, is now approved for self- or caregiver-administration in people aged 2 to 49 years, the FDA announced.
The live-attenuated vaccine contains weakened influenza viruses, as opposed to influenza vaccines given as injections, which contain inactivated viruses.
AstraZeneca announced last year that the FDA had accepted its supplemental biologics license application for FluMist to be approved as a self-administered vaccine. The application